Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma - 09/08/11
Funding sources: None. Disclosure: Dr Demierre has a significant interest in the impact of pruritus on patients with cutaneous T-cell lymphoma. In December 2005 she completed a small study of 12 patients, titled “Assessment of Pruritus and Health-related Quality of Life Measures in Patients with Cutaneous T-Cell Lymphoma (CTCL).” This study was sponsored by Merck. Both drugs discussed in this letter are not manufactured by Merck. |
Vol 55 - N° 3
P. 543-544 - septembre 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?